登录

Ronovo Surgical Closes ¥100M Series A Financing

作者: Mailman 2021-05-06 09:41
瑞龙诺赋
http://ronovo.com
企业数据由 动脉橙 提供支持
微创手术机器人研发商 | PreB轮 | 运营中
中国-上海
2023-08-30
融资金额:RMB¥2亿
纽尔利资本
查看

(VCBeat) Apr. 23, 2021 -- Shanghai Ruilong Nuofu Medical Technology Co., Ltd. ("Ronovo Surgical") announced that it has successfully completed a Series A financing of hundreds of millions. Ronovo Surgical is a medical company focusing on minimally invasive surgery (MIS) and digital surgery, committed to meeting the huge demand of the Chinese surgical market with innovative technologies.


Ronovo Surgical was founded in Shanghai in 2019, with a team of renowned roboticists and surgeons of MIS from home and abroad. Based on the national health and medical reform for the needs of the continuous improvement of clinical diagnosis and treatment, Ronovo Surgical is devoted to building an MIS and digital technology platform and ecosystem around the operating room based on self-research and global cooperation.


This round of financing is co-led by Matrix Partners China and Vivo Capital, with participation from GGV Capital and the seed round investor Lilly Asia Ventures.


Ronovo Surgical was founded in Shanghai in 2019 by industry experts from the global industry in surgery and industrial robotics, such as Zhiguan Medical, Johnson & Johnson, Medtronic, and Kuka. With strong research and development capabilities and global strategic collaboration, Ronovo Surgical accelerates the development and collaboration of MIS and digital surgery solutions and is determined to bring innovation to the traditional operating room with simplification, precision, and intelligence as the core.


>>>>

About Matrix Partners China


Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant industry-leading companies. Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have gone on to profitable M&A events. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.


>>>>

About Vivo Capital


Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high-quality companies. Since its inception, the firm has raised over $5.8 billion in capital and backed over 300 private and public portfolio companies. Vivo Capital is headquartered in Palo Alto, California, with offices in Beijing, Shanghai, Hong Kong, and Taipei.


Vivo Capital is currently making investments from its $1.4B Vivo Capital Fund IX into promising private healthcare companies and from its $635M Vivo Opportunity Fund into promising public healthcare companies.

相关赛道 医疗机器人
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

Lifted完成150万英镑种子轮融资,开发基于人工智能分析技术的护理平台

美国医疗SaaS服务商Phreesia将在纳斯达克敲钟上市,拟募资1.25亿美元

【首发】​百度收购医疗商业解决方案服务商GBI,人工智能或将推动医疗健康行业进入新纪元

与火山引擎深化内容合作,方舟健客如何做好创新患者慢病服务?

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Yrobot Announces Close Of $10 Million Series A Financing Round

2021-05-06
下一篇

E-Health Now Closes ¥10M Series A Financing

2021-05-06